Recap: Eton Pharmaceuticals Q2 Earnings

Shares of Eton Pharmaceuticals ETON fell 1.5% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 27.78% year over year to ($0.23), which beat the estimate of ($0.26).

Revenue of $20,000 up by 0.00% year over year, which missed the estimate of $290,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: Aug 12, 2020

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/5n7zmi26

Technicals

52-week high: $8.74

Company's 52-week low was at $2.50

Price action over last quarter: Up 37.05%

Company Overview

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!